vs

Side-by-side financial comparison of Arcellx, Inc. (ACLX) and Pathfinder Bancorp, Inc. (PBHC). Click either name above to swap in a different company.

Pathfinder Bancorp, Inc. is the larger business by last-quarter revenue ($11.8M vs $8.1M, roughly 1.5× Arcellx, Inc.). Pathfinder Bancorp, Inc. runs the higher net margin — -52.9% vs -766.0%, a 713.1% gap on every dollar of revenue. On growth, Pathfinder Bancorp, Inc. posted the faster year-over-year revenue change (-22.6% vs -79.3%). Pathfinder Bancorp, Inc. produced more free cash flow last quarter ($10.4M vs $-63.9M). Over the past eight quarters, Pathfinder Bancorp, Inc.'s revenue compounded faster (3.0% CAGR vs -24.6%).

Arcellx, Inc. is a clinical-stage biotechnology company that develops innovative chimeric antigen receptor T (CAR-T) cell therapies for treating hard-to-treat cancers including hematologic malignancies and solid tumors. Its core pipeline targets unmet oncology medical needs, serving global patient populations and partnering with life sciences stakeholders.

Pathfinder Bancorp, Inc. is a regional bank holding company headquartered in New York, U.S. It operates Pathfinder Bank serving the central New York market, offering retail and commercial banking services including deposit accounts, mortgages, business loans and wealth management for individual consumers and small to medium-sized enterprises.

ACLX vs PBHC — Head-to-Head

Bigger by revenue
PBHC
PBHC
1.5× larger
PBHC
$11.8M
$8.1M
ACLX
Growing faster (revenue YoY)
PBHC
PBHC
+56.7% gap
PBHC
-22.6%
-79.3%
ACLX
Higher net margin
PBHC
PBHC
713.1% more per $
PBHC
-52.9%
-766.0%
ACLX
More free cash flow
PBHC
PBHC
$74.3M more FCF
PBHC
$10.4M
$-63.9M
ACLX
Faster 2-yr revenue CAGR
PBHC
PBHC
Annualised
PBHC
3.0%
-24.6%
ACLX

Income Statement — Q1 FY2025 vs Q4 FY2025

Metric
ACLX
ACLX
PBHC
PBHC
Revenue
$8.1M
$11.8M
Net Profit
$-62.3M
$-5.6M
Gross Margin
Operating Margin
-847.6%
-81.1%
Net Margin
-766.0%
-52.9%
Revenue YoY
-79.3%
-22.6%
Net Profit YoY
-765.1%
-242.4%
EPS (diluted)
$-1.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACLX
ACLX
PBHC
PBHC
Q4 25
$11.8M
Q3 25
$13.1M
Q2 25
$9.3M
Q1 25
$8.1M
$12.6M
Q4 24
$15.3M
$15.3M
Q3 24
$26.0M
$13.4M
Q2 24
$27.4M
$10.7M
Q1 24
$39.3M
$11.1M
Net Profit
ACLX
ACLX
PBHC
PBHC
Q4 25
$-5.6M
Q3 25
$626.0K
Q2 25
$31.0K
Q1 25
$-62.3M
$3.0M
Q4 24
$-47.1M
$3.9M
Q3 24
$-25.9M
$-4.6M
Q2 24
$-27.2M
$2.0M
Q1 24
$-7.2M
$2.1M
Operating Margin
ACLX
ACLX
PBHC
PBHC
Q4 25
-81.1%
Q3 25
5.1%
Q2 25
0.4%
Q1 25
-847.6%
29.5%
Q4 24
-348.2%
55.4%
Q3 24
-129.1%
-43.1%
Q2 24
-127.8%
23.3%
Q1 24
-40.3%
24.3%
Net Margin
ACLX
ACLX
PBHC
PBHC
Q4 25
-52.9%
Q3 25
4.8%
Q2 25
0.3%
Q1 25
-766.0%
23.6%
Q4 24
-308.4%
37.7%
Q3 24
-99.4%
-34.6%
Q2 24
-99.3%
18.7%
Q1 24
-18.3%
19.0%
EPS (diluted)
ACLX
ACLX
PBHC
PBHC
Q4 25
Q3 25
$0.47
Q2 25
$0.47
Q1 25
$-1.13
Q4 24
$-0.87
Q3 24
$-0.48
$0.41
Q2 24
$-0.51
$0.41
Q1 24
$-0.14

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACLX
ACLX
PBHC
PBHC
Cash + ST InvestmentsLiquidity on hand
$543.3M
Total DebtLower is stronger
$14.1M
Stockholders' EquityBook value
$416.9M
$122.5M
Total Assets
$648.1M
$1.4B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACLX
ACLX
PBHC
PBHC
Q4 25
Q3 25
Q2 25
Q1 25
$543.3M
Q4 24
$587.4M
Q3 24
$574.3M
Q2 24
$516.7M
Q1 24
$573.9M
Total Debt
ACLX
ACLX
PBHC
PBHC
Q4 25
$14.1M
Q3 25
$18.7M
Q2 25
$21.0M
Q1 25
$17.6M
Q4 24
$27.1M
Q3 24
$39.8M
Q2 24
$45.9M
Q1 24
$45.9M
Stockholders' Equity
ACLX
ACLX
PBHC
PBHC
Q4 25
$122.5M
Q3 25
$126.3M
Q2 25
$124.4M
Q1 25
$416.9M
$124.9M
Q4 24
$454.8M
$121.5M
Q3 24
$483.0M
$120.2M
Q2 24
$487.2M
$123.3M
Q1 24
$496.6M
$121.8M
Total Assets
ACLX
ACLX
PBHC
PBHC
Q4 25
$1.4B
Q3 25
$1.5B
Q2 25
$1.5B
Q1 25
$648.1M
$1.5B
Q4 24
$711.3M
$1.5B
Q3 24
$764.9M
$1.5B
Q2 24
$734.3M
$1.4B
Q1 24
$779.7M
$1.5B
Debt / Equity
ACLX
ACLX
PBHC
PBHC
Q4 25
0.11×
Q3 25
0.15×
Q2 25
0.17×
Q1 25
0.14×
Q4 24
0.22×
Q3 24
0.33×
Q2 24
0.37×
Q1 24
0.38×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACLX
ACLX
PBHC
PBHC
Operating Cash FlowLast quarter
$-63.1M
$11.7M
Free Cash FlowOCF − Capex
$-63.9M
$10.4M
FCF MarginFCF / Revenue
-786.4%
88.1%
Capex IntensityCapex / Revenue
9.6%
10.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-122.5M
$18.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACLX
ACLX
PBHC
PBHC
Q4 25
$11.7M
Q3 25
$7.0M
Q2 25
$-3.7M
Q1 25
$-63.1M
$5.7M
Q4 24
$-46.0M
$11.2M
Q3 24
$30.7M
$11.8M
Q2 24
$-36.2M
$1.5M
Q1 24
$-31.9M
$504.0K
Free Cash Flow
ACLX
ACLX
PBHC
PBHC
Q4 25
$10.4M
Q3 25
$6.9M
Q2 25
$-4.0M
Q1 25
$-63.9M
$5.1M
Q4 24
$-47.5M
$9.1M
Q3 24
$28.4M
$11.3M
Q2 24
$-39.5M
$637.0K
Q1 24
$-38.3M
$274.0K
FCF Margin
ACLX
ACLX
PBHC
PBHC
Q4 25
88.1%
Q3 25
52.8%
Q2 25
-42.6%
Q1 25
-786.4%
40.1%
Q4 24
-311.3%
59.9%
Q3 24
109.2%
84.3%
Q2 24
-144.1%
6.0%
Q1 24
-97.7%
2.5%
Capex Intensity
ACLX
ACLX
PBHC
PBHC
Q4 25
10.7%
Q3 25
1.0%
Q2 25
2.4%
Q1 25
9.6%
5.1%
Q4 24
9.8%
13.5%
Q3 24
8.8%
3.8%
Q2 24
11.7%
8.2%
Q1 24
16.4%
2.1%
Cash Conversion
ACLX
ACLX
PBHC
PBHC
Q4 25
Q3 25
11.26×
Q2 25
-120.55×
Q1 25
1.92×
Q4 24
2.87×
Q3 24
Q2 24
0.76×
Q1 24
0.24×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACLX
ACLX

Segment breakdown not available.

PBHC
PBHC

Other$5.6M47%
Banking$3.7M31%
Deposit Account$1.5M13%
Financial Service Other$1.0M9%

Related Comparisons